These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10717607)

  • 1. The breast carcinoma screening interval is important.
    Michaelson JS; Kopans DB; Cady B
    Cancer; 2000 Mar; 88(6):1282-4. PubMed ID: 10717607
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer screening. Making sense of controversies.
    Treinen AD
    Adv Nurse Pract; 1997 May; 5(5):16-8, 21-3. PubMed ID: 9459909
    [No Abstract]   [Full Text] [Related]  

  • 3. [Screening for breast carcinoma. The need, benefit and risks].
    Thelen M
    Rofo; 1993 Nov; 159(5):409-11. PubMed ID: 8219132
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening mammography in women 40 to 49 years of age.
    Lisby MD
    Am Fam Physician; 2004 Nov; 70(9):1750-2. PubMed ID: 15554494
    [No Abstract]   [Full Text] [Related]  

  • 5. The muddle over screening breast Ca.
    Thomas P
    Med World News; 1988 May; 29(9):34-6, 42, 47-8. PubMed ID: 10312486
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of service screening mammography on population mortality from breast carcinoma.
    Feig SA
    Cancer; 2002 Aug; 95(3):451-7. PubMed ID: 12209736
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of mammography for older women.
    Finucane TE
    Ann Intern Med; 2004 May; 140(10):844; author reply 844. PubMed ID: 15148077
    [No Abstract]   [Full Text] [Related]  

  • 9. Changing guidelines for screening mammography.
    McKennett M
    West J Med; 1993 May; 158(5):520-1. PubMed ID: 8342276
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast cancer screening in older women. American Geriatrics Society Clinical Practice Committee.
    J Am Geriatr Soc; 2000 Jul; 48(7):842-4. PubMed ID: 10894327
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer screening--right or wrong?
    Chamberlain J
    Trans Med Soc Lond; 1990-1991; 107():53-7. PubMed ID: 2152425
    [No Abstract]   [Full Text] [Related]  

  • 12. New guidelines, research add to mammography controversy.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Sep; 13(18):1-2, 5. PubMed ID: 12577912
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening mammography. When should it stop?
    Byers T; Costanza ME; Kattlove H
    Cancer Pract; 1997; 5(1):52-4. PubMed ID: 9128497
    [No Abstract]   [Full Text] [Related]  

  • 14. The feasibility of breast cancer screening.
    Health Technol; 1987; 1(1):26-37. PubMed ID: 10311915
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for breast cancer in India--is it an appropriate strategy?
    Moss S
    J Natl Cancer Inst; 2008 Sep; 100(18):1270-1. PubMed ID: 18780862
    [No Abstract]   [Full Text] [Related]  

  • 16. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments and response on the USPSTF recommendation on screening for breast cancer.
    Begg CB
    Ann Intern Med; 2010 Apr; 152(8):540-1; author reply 543-4. PubMed ID: 20157101
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of life expectancy in cancer screening guidelines. Moving with caution from model-based evidence to evidence-based guidelines.
    Lantz PM; Ubel PA
    J Gen Intern Med; 2005 Jun; 20(6):552-3. PubMed ID: 15987335
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.